NCT06022822 2026-03-18Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO TrialNational Cancer Institute (NCI)Phase 2 Recruiting90 enrolled